Is it worth getting the Tdap (Tetanus, diphtheria, and pertussis) vaccine within two weeks of delivery?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 25, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Tdap Vaccination Within Two Weeks of Delivery

Getting the Tdap vaccine within two weeks of delivery is not recommended as it will not provide optimal protection for your newborn against pertussis; instead, vaccination between 27-36 weeks of pregnancy is strongly recommended for maximum benefit.

Optimal Timing for Tdap Vaccination

The Advisory Committee on Immunization Practices (ACIP) and the American College of Obstetricians and Gynecologists (ACOG) recommend administering Tdap during pregnancy between 27-36 weeks gestation 1. This timing is critical for several reasons:

  • After receiving Tdap, a minimum of 2 weeks is required to mount a maximal immune response to the vaccine antigens 2, 1
  • Maternal antibodies need time to develop and transfer to the fetus
  • Active transport of maternal immunoglobulin G does not substantially occur before 30 weeks gestation 2

Why Two Weeks Before Delivery Is Suboptimal

Receiving Tdap within two weeks of delivery provides insufficient time for:

  1. Development of maternal antibodies (takes approximately 2 weeks)
  2. Transfer of protective antibodies to the fetus
  3. Achieving adequate antibody levels in the newborn

Effectiveness of Maternal Tdap Vaccination

When administered at the recommended time (27-36 weeks):

  • Maternal Tdap vaccination is 80-91% effective in preventing infant pertussis 2, 1
  • Reduces hospitalization among infected infants by 58% 1
  • Provides 91.4% effectiveness during the first 2 months of life 3

Studies show that maternal vaccination during pregnancy is significantly more effective than postpartum vaccination:

  • Postpartum vaccination is 85% less effective at preventing infant pertussis 1
  • Maternal antibody levels at delivery are significantly higher when vaccinated during pregnancy vs. postpartum (51.0 EU/mL vs. 9.1 EU/mL) 4
  • Infant antibody levels at birth are significantly higher with maternal vaccination during pregnancy (68.8 EU/mL vs. 14.0 EU/mL) 4

Alternative Approaches If Not Vaccinated During Pregnancy

If you haven't received Tdap during the optimal window (27-36 weeks):

  1. If still pregnant but close to delivery: While not ideal, receiving Tdap even within two weeks of delivery may provide some limited protection and is better than no vaccination 2

  2. After delivery: If Tdap was not administered during pregnancy, it should be given immediately postpartum before discharge from the hospital 2, 1

  3. Cocooning strategy: Ensure all household contacts and caregivers receive Tdap if they haven't previously received it 2, 1

Important Considerations

  • Pertussis causes the highest morbidity and mortality in infants under 3 months of age 5
  • Infants don't begin their own vaccine series against pertussis until approximately 2 months of age 5
  • Maternal antibodies wane quickly; vaccination during each pregnancy is necessary 2, 1
  • Preterm infants are at highest risk for pertussis and benefit particularly from maternal vaccination 6

Conclusion

The evidence strongly supports vaccination during the recommended window of 27-36 weeks gestation, preferably earlier in this range. Getting Tdap within two weeks of delivery significantly reduces the protective benefit for your newborn and is not the recommended approach for optimal protection against pertussis.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.